Ricerca avanzata

Home > Riviste > Minerva Cardioangiologica > Fascicoli precedenti > Articoli online first > Minerva Cardioangiologica 2016 Sep 07



Rivista sulle Malattie del Cuore e dei Vasi

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752

Periodicità: Bimestrale

ISSN 0026-4725

Online ISSN 1827-1618


Minerva Cardioangiologica 2016 Sep 07

Helicobacter pylori infection and ischemic heart disease: could experimental data lead clinical studies?

Davide G. RIBALDONE 1, Sharmila FAGOONEE 2, Ingrid HICKMAN 3, Fiorella ALTRUDA 4, Giorgio M. SARACCO 1, 3, Rinaldo PELLICANO 1

1 Unit of Gastroenterology, Molinette Hospital, Turin, Italy; 2 Institute for Biostructures and Bioimages (CNR) c/o Molecular Biotechnology Center, University of Turin, Turin, Italy; 3 Department of Nutrition and Dietetics, Princess Alexandra Hospital, Woolloongabba, Australia; 4 Molecular Biotechnology Center, University of Turin, Turin, Italy

Despite the remarkable advances made in primary prevention and treatment, ischemic heart disease (IHD) remains the leading cause of death and a significant cause of disability in developed countries. Since traditional cardiovascular risk factors failed to predict all cases of IHD, there is an intensive research to explore other potential etiologic factors. Among these, numerous studies have considered the theoretical link between IHD and chronic infections, including Helicobacter pylori (H. pylori). Considering that epidemiologic studies have produced conflicting results, due to geographical variations of IHD and H. pylori prevalence as well as heterogeneity of study designs, an alternative way to analyze this topic is to assess if consistency for a biological plausibility exists. In this review we critically analyzed the experimental data on this topic, to assess whether their results could lead future clinical studies.

lingua: Inglese


inizio pagina